Sanofi marches further into China's rural market

11 October 2018
sanofi-big-2

The China subsidiary of French pharma major Sanofi (Euronext: SAN) on October 8 signed a strategic agreement with the Association of County Hospital President, a government-backed organization aiming to improve clinical practices in China’s rural areas, reports The Pharma Letter’s local correspondent Wang Fangqing.

Under the agreement, Sanofi and the association, which was initiated in May by Wang Delong, former deputy minister of China’s Ministry of Health, will focus on training medical talent in major chronic diseases including oncology, diabetes, respiratory disease and cardiovascular disease, all  among Sanofi’s core businesses.

China has over 5,000 county-level hospitals nationwide, but they in general lack medical talent and essential skills that could match hospitals in big Chinese cities, causinghigh mortality rate and unnecessary financial burdens in rural areas, according to the association.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical